These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20818173)

  • 41. Expression and Subcellular Localization of the Kaposi's Sarcoma-Associated Herpesvirus K15P Protein during Latency and Lytic Reactivation in Primary Effusion Lymphoma Cells.
    Smith CG; Kharkwal H; Wilson DW
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation.
    Sun Q; Zachariah S; Chaudhary PM
    J Biol Chem; 2003 Dec; 278(52):52437-45. PubMed ID: 14563855
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
    Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
    Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Viral inhibitor of apoptosis vFLIP/K13 protects endothelial cells against superoxide-induced cell death.
    Thurau M; Marquardt G; Gonin-Laurent N; Weinländer K; Naschberger E; Jochmann R; Alkharsah KR; Schulz TF; Thome M; Neipel F; Stürzl M
    J Virol; 2009 Jan; 83(2):598-611. PubMed ID: 18987137
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stimulation of c-Myc transcriptional activity by vIRF-3 of Kaposi sarcoma-associated herpesvirus.
    Lubyova B; Kellum MJ; Frisancho JA; Pitha PM
    J Biol Chem; 2007 Nov; 282(44):31944-53. PubMed ID: 17728244
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In primary effusion lymphoma cells, MYB transcriptional repression is associated with v-FLIP expression during latent KSHV infection while both v-FLIP and v-GPCR become involved during the lytic cycle.
    Lacoste V; Nicot C; Gessain A; Valensi F; Gabarre J; Matta H; Chaudhary PM; Mahieux R
    Br J Haematol; 2007 Aug; 138(4):487-501. PubMed ID: 17659053
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation.
    Sun Q; Matta H; Lu G; Chaudhary PM
    Oncogene; 2006 May; 25(19):2717-26. PubMed ID: 16418726
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of NF-kappaB inhibitor IkappaBalpha and viral replication by a KSHV microRNA.
    Lei X; Bai Z; Ye F; Xie J; Kim CG; Huang Y; Gao SJ
    Nat Cell Biol; 2010 Feb; 12(2):193-9. PubMed ID: 20081837
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters.
    Wang SE; Wu FY; Yu Y; Hayward GS
    J Virol; 2003 Sep; 77(17):9590-612. PubMed ID: 12915572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Deregulation of c-Myc in primary effusion lymphoma by Kaposi's sarcoma herpesvirus latency-associated nuclear antigen.
    Bubman D; Guasparri I; Cesarman E
    Oncogene; 2007 Jul; 26(34):4979-86. PubMed ID: 17310999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
    Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma.
    Ishikawa C; Mori N
    Invest New Drugs; 2021 Feb; 39(1):111-121. PubMed ID: 32885355
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of bortezomib in a direct xenograft model of primary effusion lymphoma.
    Sarosiek KA; Cavallin LE; Bhatt S; Toomey NL; Natkunam Y; Blasini W; Gentles AJ; Ramos JC; Mesri EA; Lossos IS
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13069-74. PubMed ID: 20615981
    [TBL] [Abstract][Full Text] [Related]  

  • 56. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
    Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
    J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multi-targeted therapy of everolimus in Kaposi's sarcoma associated herpes virus infected primary effusion lymphoma.
    Mohanty S; Kumar A; Das P; Sahu SK; Choudhuri T
    Apoptosis; 2017 Sep; 22(9):1098-1115. PubMed ID: 28653223
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The KSHV oncoprotein vFLIP contains a TRAF-interacting motif and requires TRAF2 and TRAF3 for signalling.
    Guasparri I; Wu H; Cesarman E
    EMBO Rep; 2006 Jan; 7(1):114-9. PubMed ID: 16311516
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunomodulatory drugs target IKZF1-IRF4-MYC axis in primary effusion lymphoma in a cereblon-dependent manner and display synergistic cytotoxicity with BRD4 inhibitors.
    Gopalakrishnan R; Matta H; Tolani B; Triche T; Chaudhary PM
    Oncogene; 2016 Apr; 35(14):1797-810. PubMed ID: 26119939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.